Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

EGF-induced regulation of human Gamma-enolase interactome

ABSTRACT: EGF-induced regulation of Gamma-enolase protein complexes was analyzed using anti-Gamma-enolase monoclonal antibodies designed to immunoreact with the C-terminus of human Gamma-enolase protein.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Masaaki Oyama

PROVIDER: PXD070141 | JPOST Repository | Sun May 17 00:00:00 BST 2026

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	20251021_GB2_4_E15_Enolase_FAIMS_09.raw	Raw
	20251021_GB2_7_E60_Enolase_FAIMS_05.raw	Raw
	20251024_PD31_SP-MetDB_20251021_GB2_4_E15_Enolase_FAIMS_09.xlsx	Xlsx
	20251024_PD31_SP-MetDB_20251021_GB2_7_E60_Enolase_FAIMS_05.xlsx	Xlsx

Items per page:

1 - 4 of 4

Publications

Real-time search-assisted multiplexed quantitative proteomics reveals system-wide cryptic translation initiation in human cancer cells.

Kozuka-Hata Hiroko H Hiroki Tomoko T Kitamura Aya A Miyamura Naoaki N Akiyama Tetsu T Inoue Jun-Ichiro JI Tsumoto Kouhei K Oyama Masaaki M

Genome biology 20260528

<h4>Background</h4>It is generally considered that eukaryotic translation initiation prominently occurs from the first AUG codon by ribosomal scanning from the 5-cap end of each mRNA. In order to identify cryptic internal translation initiation sites defined by alternative AUG codons on a proteome-wide scale, we generate a customized amino acid sequence database which contain differential AUG-guided tryptic peptide fragments computationally predicted from well-curated Swiss-Prot human protein re ...[more]

PMID: 42204619

Similar Datasets

Grb2 interactome data with and without EGF stimulation

Project description:Growth factor receptor-bound protein 2 or Grb2 is an adaptor protein involved in signal transduction. It is widely expressed and integral to several cellular functions, including cell proliferation. We designed this study to capture interacting partners of Grb2 in absence and presence of epidermal growth factor (EGF). HEK 293 cells, expressing tagged Grb2, were cultured with SILAC labels in presence and absence of EGF. Grb2 interactome was enriched by immunoprecipitation and subjected to mass spectrometry. This data will help in understanding the regulatory effect of EGF stimulation on Grb2 protein and its interactors.

2019-03-05 | PXD012957 | Pride

ADAM17 is required for EGF-R induced intestinal tumors via IL-6 trans-signaling

Project description:Colorectal cancer is treated with antibodies blocking epidermal growth factor receptor (EGF-R) but therapeutic success is limited. EGF-R is stimulated by soluble ligands, which are derived from transmembrane precursors by ADAM17-mediated proteolytic cleavage. In mouse intestinal cancer models in the absence of ADAM17, tumorigenesis was almost completely inhibited and the few remaining tumors were of low grade dysplasia. RNA-Seq analysis demonstrated downregulation of STAT3 and Wnt pathway components. Since EGF-R on myeloid cells, but not on intestinal epithelial cells is required for intestinal cancer and IL-6 is induced via EGF-R stimulation, we analyzed the role of IL-6 signaling. Tumor formation was equally inhibited in IL-6 -/- and sgp130Fc transgenic mice, in which only trans-signaling via soluble IL-6R is abrogated. ADAM17 is needed for EGF-R-mediated induction of IL-6 synthesis, which via IL-6 trans-signaling induces ß-catenin dependent tumorigenesis. Our data reveal the possibility of a novel strategy for treatment of colorectal cancer, which could circumvent intrinsic and acquired resistance to EGF-R blockade.

2018-02-19 | GSE107759 | GEO

Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer

Project description:RATIONALE: Monoclonal antibodies such as ABX-EGF can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of monoclonal antibody ABX-EGF in treating patients who have either renal (kidney), prostate, pancreatic, non-small cell lung, colon, rectal, esophageal, or gastroesophageal junction cancer.

| 2004026 | ecrin-mdr-crc

EGF-induced Transcriptome Changes in GBM stem-like cells

Project description:GBM neurosphere line GBM1B were depleted of growth factors for 16 hours followed by EGF stimulation for 4 and 24 hours. RNA-seq was used to identify differentially-expressed (DE) genes after EGF treatment.

2021-04-19 | GSE151995 | GEO

Genomewide analysis of EGF-induced alternative splicing

Project description:We performed EGF treatment and hnRNP A1 knockdown in HeLa cells and analyzed alternative splicing patterns by high-throughput RNA sequencing.

2017-03-01 | GSE92939 | GEO

Effect of MIEN1-Based Peptide LA3IK on Gene Expression in EGF-Induced PC3 Prostate Cancer Cells at 0h, 30 Minutes, 1h, and 6h Time Points

Project description:This RNA-seq dataset investigates the effect of the MIEN1-based peptide LA3IK on the gene expression patterns of EGF-induced PC3 prostate cancer cells at four distinct time points: 0h (untreated), 30 minutes, 1 hour, and 6 hours. EGF stimulation was used to activate key signaling pathways involved in cell proliferation and survival, mimicking conditions associated with cancer progression. The LA3IK peptide, designed to target MIEN1, was introduced to evaluate its modulatory effects on the transcriptomic response to EGF over time. By capturing the gene expression changes at these intervals, this study seeks to identify the specific molecular pathways and gene networks influenced by LA3IK, providing insights into its potential therapeutic role in modulating EGF-driven oncogenic processes in prostate cancer. The data will contribute to a better understanding of how LA3IK might disrupt tumor-promoting signals and its possible application in cancer therapy.

2026-04-22 | GSE279005 | GEO

Human Mammary Epithelial Cell Response to EGF, microarray analysis

Project description:To understand how integration of multiple data types can help decipher cellular responses at the systems level, we analyzed the mitogenic response of human mammary epithelial cells to epidermal growth factor (EGF) using whole genome microarrays, mass spectrometry-based proteomics and large-scale western blots with over 1000 antibodies. A time course analysis revealed significant differences in the expression of 3172 genes and 596 proteins, including protein phosphorylation changes measured by western blot. Integration of these disparate data types showed that each contributed qualitatively different components to the observed cell response to EGF and that varying degrees of concordance in gene expression and protein abundance measurements could be linked to specific biological processes. Networks inferred from individual data types were relatively limited, whereas networks derived from the integrated data recapitulated the known major cellular responses to EGF and exhibited more highly connected signaling nodes than networks derived from any individual dataset. While cell cycle regulatory pathways were altered as anticipated, we found the most robust response to mitogenic concentrations of EGF was induction of matrix metalloprotease cascades, highlighting the importance of the EGFR system as a regulator of the extracellular environment. These results demonstrate the value of integrating multiple levels of biological information to more accurately reconstruct networks of cellular response. Keywords: time-course analysis

2010-04-14 | GSE15668 | GEO

Epidermal growth factor dampens pro-inflammatory gene expression induced by interferon-gamma in global transcriptome analysis of keratinocytes

Project description:The impact of EGFR ligands (i.e. EGF) on interferon signaling is unclear. The purpose of this study was to investigate the impact of EGF on IFN-γ transcriptional responses on a genome-wide scale in keratinocytes. RNA-seq was performed in human keratinocyte (HaCaT) cells treated with IFN-γ, EGF, both, or neither (control). Differentially expressed genes (DEGs) in each treatment group, relative to control, were identified using DESeq2. Our findings suggest that the pro-inflammatory IFN-γ-induced transcriptome may be globally attenuated by EGF in keratinocytes, supporting an anti-inflammatory role of EGF in the skin.

2025-01-09 | GSE279122 | GEO

EGF-induced Transcriptome Changes in GBM stem-like cells

Project description:EGF-induced Transcriptome Changes in GBM stem-like cells

| PRJNA638032 | ENA

Expression data from normal human epidermal keratinocytes undergoing density-induced differentiation and treated with EGF

Project description:Combining genome-wide microarray and functional analyses, we found that EGFR activation abrogates barrier function, increasing transepidermal water loss (TEWL) and transepithelial permeability of water-soluble ions and higher molecular weight dextrans, in part by disrupting the expression of tight junction proteins. EGF decreases certain lipid matrix free fatty acids and ceramides by its actions to repress the expression of specific biosynthetic enzymes. Activation of EGFR inhibits cornified envelope formation by regulating the expression of 59 percent of the known contributing genes. EGF-responsiveness enriches more than 100 genes known to be associated with skin diseases. These data are used to obtain 2,676 density-dependent genes that are differentially expressed in response to EGF treatment.

2012-05-03 | GSE32217 | GEO